Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€6.79

€6.79

-2.890%
-0.202
-2.890%
€7.75

€7.75

 
26.04.24 / Tradegate WKN: A16140 / Name: HelloFresh / Stock / Food & Drug Retailing / Micro Cap /
Latest predictions
12.04.24
4.40%
buy
22.03.24
2.60%
€8.00
16.03.24
-10.19%
buy
€7.50
15.03.24
0.30%
buy
12.03.24
-3.85%
buy
09.03.24
-1.79%
buy
Your prediction

HelloFresh SE Stock

A loss of -2.890% shows a downward development for HelloFresh SE.
We see a rather positive sentiment for HelloFresh SE with 9 Buy predictions and 1 Sell predictions.
As a result the target price of 7 € shows a slightly positive potential of 3.12% compared to the current price of 6.79 € for HelloFresh SE.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for HelloFresh SE stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of HelloFresh SE in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of HelloFresh SE vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
HelloFresh SE -2.890% 0.474% 1.830% -72.999% -52.565% -90.157% -
DAVIDsTEA Inc - -2.577% -22.541% -54.785% -58.370% -93.000% -85.703%
George Weston Ltd. -0.810% 1.667% -3.175% 2.521% 9.910% 64.865% 83.541%
Empire Co. Ltd A 0.930% 1.869% -0.909% -9.917% -7.627% -16.154% 10.817%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

HelloFresh, a leading company in the Food & Drug Retailing industry, has demonstrated impressive financial performance over the past few years. The robust growth in total revenues, consistent improvement of net income, and strong balance sheet showcases a promising future for the company. However, it is essential to dive deeper into the financial statements to understand the strengths and weaknesses of HelloFresh before making any investment decision.

*Pros: *

Revenue Growth: HelloFresh has experienced remarkable revenue growth, with total revenues increasing from €3.75 billion in 2020 to €7.61 billion in 2022. This consistent revenue growth is a strong indicator of the company's market penetration and growing customer base.

Comments

Buy HelloFresh SE
Show more

Buy HelloFresh SE
Show more

Buy HelloFresh SE
Show more

News

EQS-News: HelloFresh SE reports quarterly revenue of approx. €2.07 bn Ready-to-Eat product category growing quickly and expanding to further countries
EQS-News: HelloFresh SE reports quarterly revenue of approx. €2.07 bn Ready-to-Eat product category growing quickly and expanding to further countries
EQS-News: HelloFresh SE reports quarterly revenue of approx. €2.07 bn Ready-to-Eat product category growing quickly and expanding to further countries
EQS-News: HelloFresh SE reports €7.6bn consolidated revenue for the FY 2023 and returns to positive free cash flow
EQS-News: HelloFresh SE reports €7.6bn consolidated revenue for the FY 2023 and returns to positive free cash flow
EQS-News: HelloFresh SE reports €7.6bn consolidated revenue for the FY 2023 and returns to positive free cash flow
EQS-Adhoc: HelloFresh SE met outlook for the fiscal year 2023, provides outlook for the fiscal year 2024 and removes its midterm targets
EQS-Adhoc: HelloFresh SE met outlook for the fiscal year 2023, provides outlook for the fiscal year 2024 and removes its midterm targets
EQS-Adhoc: HelloFresh SE met outlook for the fiscal year 2023, provides outlook for the fiscal year 2024 and removes its midterm targets